Comparsion of levetiracetam and sodium valproate mono therapy in childhood epilepsy
Not Applicable
- Conditions
- Health Condition 1: null- newly diagnosed childhood epilepsy
- Registration Number
- CTRI/2017/11/010605
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed focal motor or generalised epilepsy
Exclusion Criteria
1.Children who are on anti epileptic for more than 15 days
2.Children with congenital anomalies or developmental delay or microcephaly
3.Acute head trauma or post traumatic epilepsy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Treatment will be considered successful if there is no repeat seizure activity for 6 monthsTimepoint: Treatment will be considered successful if there is no repeat seizure activity for 6 months
- Secondary Outcome Measures
Name Time Method 1.Side effect profile of the patients in each group <br/ ><br>2.Achievement of therapeutic drug levels at steady state and 6 months <br/ ><br>3.Time to first seizure after steady state of drugTimepoint: 6 months